Trump funding cuts may force Alzheimer’s disease study to shut down, affecting 600 aging adults
Summary
The Trump administration cut funding for a federal Alzheimer’s disease study involving 600 aging adults in two low-income, mostly Black neighborhoods in Pittsburgh. This early shutdown prevents researchers from analyzing and sharing important data, which could delay diagnosis and treatment for these participants.Key Facts
- The study focused on Alzheimer’s disease risk in two majority Black, low-income Pittsburgh neighborhoods.
- The Trump administration canceled the research grant in August and gave researchers 90 days to close the study, more than five months earlier than planned.
- Researchers cannot complete data analysis or share cognitive test results with participants due to lack of time and money.
- Over the last two years, the administration canceled or froze more than 5,700 medical research grants funded by NIH, affecting over 74,000 clinical trial participants nationally.
- The cuts are tied to the Trump administration’s changes in federal science funding, including efforts against diversity, equity, and inclusion (DEI) programs.
- Researchers are suing the NIH, claiming the government is censoring research that conflicts with political views.
- Black Americans are twice as likely to get Alzheimer’s disease but are underrepresented in research studies.
- Early diagnosis of Alzheimer’s is important because treatments work best in the early stages and can help slow disease progression.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
